+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine



Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine



Current Stem Cell Research and Therapy 6(3): 221-228



Mesenchymal Stem Cells (MSCs), have been defined and characterized by: 1) their ability to adhere to plastic culture flasks; 2) the positive expression of CD105, CD73, CD90 membrane antigens, and the lack of expression of others (e.g CD45 and CD34) and 3) the ability of differentiation under adequate conditions along the osteogenic, chondrogenic and adipogenic lineages. In recent years cells with these characteristics have been isolated from the Wharton Jelly (WJ) of the Umbilical Cord (UC). Similarly to bone marrow MSCs they have shown multilineage differentiation potential and to be able to provide trophic support to neighboring cells. According to the literature, there are two main populations of cells with a mesenchymal character within the human UC: Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs) and Human Umbilical Cord Perivascular Cells (HUCPVCs). In the present work our aim is to make a comprehensive review on MSCs populations of the WJ and how these cell populations may be used for future applications in CNS regenerative medicine. Following a brief insight on the general characteristics of MSC like cells, we will discuss the possible sources of stem cells within the WJ and the cord itself (apart UC blood), as well as their phenotypic character. As it has already been shown that these cells hold a strong trophic support to neighbouring cell populations, we will then focus on their secretome, namely which molecules have already been identified within it and their role in phenomena such as immunomodulation. The possible applications of these cells populations to CNS regenerative medicine will be addressed by critically reviewing the work that has been performed so far in this field. Finally, a brief insight will be made on what in the authors' opinion are the major challenges in the field for the future application of these cell populations in CNS regenerative medicine.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 054333843

Download citation: RISBibTeXText

PMID: 21476975


Related references

Mesenchymal Stem Cells in the Umbilical Cord: Phenotypic Characterization, Secretome and Applications in Central Nervous System Regenerative Medicine. Current Stem Cell Research & Therapy 6(3): 221-228, 2011

Morpho-functional characterization of human mesenchymal stem cells from umbilical cord blood for potential uses in regenerative medicine. Stem Cells and Development 18(2): 293-305, 2009

Characterization of Regenerative Phenotype of Unrestricted Somatic Stem Cells (USSC) from Human Umbilical Cord Blood (hUCB) by Functional Secretome Analysis. Molecular and Cellular Proteomics 14(10): 2630-2643, 2015

Tips on How to Collect and Administer the Mesenchymal Stem Cell Secretome for Central Nervous System Applications. Methods in Molecular Biology 1416: 457-465, 2016

Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?. Cellular and Molecular Life Sciences 70(20): 3871-3882, 2013

Secretome of mesenchymal stem/stromal cells in regenerative medicine. Biochimie 95(12): 2195, 2013

Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis. Stem Cells Translational Medicine 1(7): 536-547, 2012

Mesenchymal stem cells secretome: a new therapeutic tool for Parkinsons disease regenerative medicine?. European Neuropsychopharmacology 27: S687-S688, 2017

Umbilical cord tissue mesenchymal stem cells: characterization and clinical applications. Current Stem Cell Research and Therapy 8(5): 394-399, 2013

Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases role of secretome and exosomes. Biochimie, 2013

Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. Biochimie 95(12): 2229-2234, 2013

Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods 99: 62-68, 2016

Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma. Stem Cells and Development 20(7): 1199-1212, 2011

The therapeutic effect of secretome from human umbilical cord-derived mesenchymal stem cells in age-related osteoporosis. Artificial Cells Nanomedicine and Biotechnology 47(1): 1357-1366, 2019

Human umbilical cord mesenchymal stromal cells in regenerative medicine. Stem Cell Research and Therapy 4(6): 142, 2013